Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A13

    

• International Perspectives on Cardiovascular Research

  • ·Regional challenges and opportunities in cardiovascular research: The Russian Federation “SWOT” analysis

    Page :427-430

    Sergey Boytsov, Frans Van de Werf

    Plan Plan
  • ·Cardiovascular research in India: A perspective

    Page :431-438

    Ajay S. Vamadevan, Bimal R. Shah, Robert M. Califf, Dorairaj Prabhakaran

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·Ultrafiltration in heart failure

    Page :439-449

    Enrico Fiaccadori, Giuseppe Regolisti, Umberto Maggiore, Elisabetta Parenti, Elena Cremaschi, Simona Detrenis, Alberto Caiazza, Aderville Cabassi

    Résumé Résumé Plan Plan  
  • ·Oral antiplatelet therapy for atherothrombotic disease: Current evidence and new directions

    Page :450-461

    Harvey D. White

    Résumé Résumé Plan Plan  
  • ·Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions

    Page :462-470

    Davide Capodanno, Corrado Tamburino

    Résumé Résumé Plan Plan  

• Trial Design

  • ·The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol : Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH)

    Page :471

    The AIM-HIGH Investigators a b ?

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction

    Page :478

    C. Michael Gibson, Akiko Maehara, Alexandra J. Lansky, Jochen Wohrle, Tom Stuckey, Rajesh Dave, David Cox, Cindy Grines, Dariusz Dudek, Gabriel Steg, Helen Parise, Steven D. Wolff, Ecaterina Cristea, Gregg W. Stone

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

    Page :487-493

    Barry Trachtenberg, Darcy L. Velazquez, Adam R. Williams, Ian McNiece, Joel Fishman, Kim Nguyen, Didier Rouy, Peter Altman, Richard Schwarz, Adam Mendizabal, Behzad Oskouei, John Byrnes, Victor Soto, Melissa Tracy, Juan Pablo Zambrano, Alan W. Heldman, Joshua M. Hare

    Résumé Résumé Plan Plan  
  • ·Etanercept as adjunctive treatment for acute kawasaki disease: Study design and rationale

    Page :494-499

    Michael A. Portman, Aaron Olson, Brian Soriano, Nagib Dahdah, Richard Williams, Edward Kirkpatrick

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration

    Page :500

    Sanneke P.M. de Boer, Elizabeth H. Barnes, Cynthia M. Westerhout, R. John Simes, Christopher B. Granger, Adnan Kastrati, Petr Widimsky, Menko Jan de Boer, Felix Zijlstra, Eric Boersma

    Résumé Résumé Plan Plan  
  • ·Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: Relation to bifurcations and curvatures

    Page :508-515

    Michael C. McDaniel, Erin M. Galbraith, Ahmad M. Jeroudi, Omar R. Kashlan, Parham Eshtehardi, Jin Suo, Saurabh Dhawan, Michele Voeltz, Chandan Devireddy, John Oshinski, David G. Harrison, Don P. Giddens, Habib Samady

    Résumé Résumé Plan Plan  
  • ·Lipoprotein-associated phospholipase A₂ activity improves risk discrimination of incident coronary heart disease among women

    Page :516-522

    Ida J. Hatoum, Nancy R. Cook, Jeanenne J. Nelson, Kathryn M. Rexrode, Eric B. Rimm

    Résumé Résumé Plan Plan
  • ·Cardiovascular abnormalities in adults with osteogenesis imperfecta

    Page :523-529

    Zoran Radunovic, Lena L. Wekre, Lien M. Diep, Kjetil Steine

    Résumé Résumé Plan Plan  
  • ·A comparison of echocardiographic measures of diastolic function for predicting all-cause mortality in a predominantly male population

    Page :530-537

    Patricia K. Nguyen, Ingela Schnittger, Paul A. Heidenreich

    Résumé Résumé Plan Plan  
  • ·The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial

    Page :538-543

    The AIM-HIGH Investigators a b ?

    Résumé Résumé Plan Plan
  • ·Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary intervention

    Page :544

    Krishna G. Aragam, Mauro Moscucci, Dean E. Smith, Arthur L. Riba, Mark Zainea, James L. Chambers, David Share, Hitinder S. Gurm

    Résumé Résumé Plan Plan  
  • ·Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy

    Page :552-557

    Miriam Shanks, Victoria Delgado, Arnold C.T. Ng, Dominique Auger, Eline A.Q. Mooyaart, Matteo Bertini, Nina Ajmone Marsan, Rutger J. van Bommel, Eduard R. Holman, Don Poldermans, Martin J. Schalij, Jeroen J. Bax

    Résumé Résumé Plan Plan
  • ·Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure

    Page :558-566

    William T. Abraham, Philip B. Adamson, Ayesha Hasan, Robert C. Bourge, Salpy V. Pamboukian, Mark F. Aaron, Nirav Y. Raval

    Résumé Résumé Plan Plan  
  • ·Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship

    Page :567-573

    Sameer Ather, Wenyaw Chan, Annirudha Chillar, David Aguilar, Allison M. Pritchett, Kumudha Ramasubbu, Xander H.T. Wehrens, Anita Deswal, Biykem Bozkurt

    Résumé Résumé Plan Plan  
  • ·Increase in sudden death from coronary artery disease in young adults

    Page :574-580

    Dabit Arzamendi, Begoña Benito, Helena Tizon-Marcos, Jose Flores, Jean François Tanguay, Hung Ly, Serge Doucet, Louis Leduc, Tack Ki Leung, Oscar Campuzano, Anna Iglesias, Mario Talajic, Ramon Brugada

    Résumé Résumé Plan Plan  
  • ·Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)

    Page :581-589

    Krzysztof Kuku?a, Lidia Chojnowska, Maciej D?browski, Adam Witkowski, Zbigniew Chmielak, Miros?aw Skwarek, Jacek K?dziela, Anna Teresi?ska, Maciej Ma?ecki, Przemys?aw Janik, Zbigniew Lewandowski, Mariusz K?opotowski, Jacek Wnuk, Witold Ru?y??o

    Résumé Résumé Plan Plan  
  • ·Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease

    Page :590-597

    Kashish Goel, Randal J. Thomas, Ray W. Squires, Thais Coutinho, Jorge F. Trejo-Gutierrez, Virend K. Somers, John M. Miles, Francisco Lopez-Jimenez

    Résumé Résumé Plan Plan  
  • ·The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy

    Page :598-604

    Paul A. Gurbel, Alan R. Shuldiner, Kevin P. Bliden, Kathaleen Ryan, Ruth E. Pakyz, Udaya S. Tantry

    Résumé Résumé Plan Plan  
  • ·Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting

    Page :605-610

    Nikolaus Sarafoff, Lydia Neumann, Tanja Morath, Isabell Bernlochner, Julinda Mehilli, Albert Schömig, Adnan Kastrati, Dirk Sibbing

    Résumé Résumé Plan Plan  
  • ·The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone

    Page :611-621

    James E. Udelson, Camille A. Pearte, Carey D. Kimmelstiel, Mariusz Kruk, Joseph A. Kufera, Sandra A. Forman, Anna Teresinska, Bartosz Bychowiec, Jose Antonio Marin-Neto, Thomas Höchtl, Eric A. Cohen, Paulo Caramori, Benita Busz-Papiez, Christopher Adlbrecht, Zygmunt P. Sadowski, Witold Ruzyllo, Debra J. Kinan, Gervasio A. Lamas, Judith S. Hochman

    Résumé Résumé Plan Plan  
  • ·Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trials

    Page :622

    Dharam J. Kumbhani, Anthony A. Bavry, James E. Harvey, Russell de Souza, Roberto Scarpioni, Deepak L. Bhatt, Samir R. Kapadia

    Résumé Résumé Plan Plan  
  • ·Angina frequency after myocardial infarction and quality of life in older versus younger adults: The Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study

    Page :631-638

    Ryan B. Longmore, John A. Spertus, Karen P. Alexander, Kensey Gosch, Kimberly J. Reid, Frederick A. Masoudi, Harlan M. Krumholz, Michael W. Rich

    Résumé Résumé Plan Plan  
  • ·Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)

    Page :639

    Sarah J. Lagedrost, Martin St. John Sutton, Meryl S. Cohen, Gary M. Satou, Beth D. Kaufman, Susan L. Perlman, Christian Rummey, Thomas Meier, David R. Lynch

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·The ancient and often incorrect units for the ventricular stroke work should be replaced by an SI unit

    Page :e9

    Wolfgang Schramm, Bily Notley

    
  • ·Response to Letter to the Editor by Schramm, MD, and Notley, MD

    Page :e11

    Lynn Sleeper

    
  • ·Time to ferry heart failure onto new shores: The need to effectively customize long-term therapy

    Page :e13

    Gaspare Parrinello, Daniele Torres, Salvatore Paterna, Giuseppe Licata, Pietro Di Pasquale

    
  • ·Dynamic furosemide dose: A marker of adverse heart failure outcomes

    Page :e15

    Husam M. Abdel-Qadir, Jack V. Tu, Gary E. Newton, Peter C. Austin, Douglas S. Lee